SCHEMBL5372155

SCHEMBL5372155

COC(=O)c1cc(S(=O)(=O)Nc2ccc(-c3nc4ccc(C)cc4s3)cc2)ccc1C(C)C

nearest known ligand 0.66

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 11/20 0.66
ALDH1A1 P00352 10/20 0.66
HPGD P15428 9/20 0.66
KDM4E B2RXH2 9/20 0.66
RORC P51449 8/20 0.66
GAA P10253 6/20 0.66
GLA P06280 4/20 0.66
NPC1 O15118 9/20 0.66
RAB9A P51151 8/20 0.66
SMN1; SMN2 Q16637 7/20 0.66
MEN1 O00255 6/20 0.66
KMT2A Q03164 6/20 0.66
LMNA P02545 3/20 0.66
NFKB1 P19838 1/20 0.62
HTT P42858 1/20 0.62
NFKB2 Q00653 1/20 0.62
RELA Q04206 1/20 0.62
HSP90AA1 P07900 1/20 0.62
RXFP1 Q9HBX9 1/20 0.51
TP53 P04637 2/20 0.51

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5369912 0.92 ALDH1A1 (0.70) MAPTALDH1A1HPGDKDM4ERORC
SCHEMBL5368694 0.87 RORC (0.67) MAPTALDH1A1HPGDKDM4ERORC
SCHEMBL5376800 0.85 MAPT (0.67) MAPTALDH1A1HPGDKDM4ERORC
SCHEMBL5373408 0.82 ALDH1A1 (0.57) MAPTALDH1A1HPGDKDM4ERORC
SCHEMBL5380411 0.82 MAPT (0.74) MAPTALDH1A1HPGDKDM4ERORC
SCHEMBL3735493 0.81 RORC (1.00) MAPTALDH1A1HPGDKDM4ERORC
SCHEMBL5382225 0.80 MAPT (0.71) MAPTALDH1A1HPGDKDM4ERORC
SCHEMBL5371897 0.79 ALDH1A1 (0.70) MAPTALDH1A1HPGDKDM4ERORC
SCHEMBL5921927 0.79 PTPN2 (0.62) MAPTALDH1A1HPGDKDM4EGAA
SCHEMBL5390777 0.79 ALDH1A1 (0.81) MAPTALDH1A1HPGDKDM4ERORC

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-7262318-B2 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER, INC. (US) 2007-08-28 US disclosed
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PFIZER INC 2006-11-16 US disclosed
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PFIZER INC 2005-10-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050228015-A1 Substituted heteroaryl- and phenylsulfamoyl compounds PPARA, PPARG, PPARD MAPT 1786/4885ALDH1A1 2956/4885HPGD 724/4885
US-20060258723-A1 Substituted Heteroaryl- and Phenylsulfamoyl Compounds PPARG, PPARA, PPARD MAPT 1984/4885ALDH1A1 2752/4885HPGD 696/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.